MannKind Corporation (MNKD) will release its 2012 fourth quarter and full year financial results on Monday, February 11, 2013 and its management will host a conference call to discuss the fourth quarter and full year financial results and other Company developments at 5:00 PM (Eastern Time) on February 11, 2013.
Expect an update on the the Afrezza trials that are expected to be completed in April. Also the company has two partnerships for development of its cancer drugs that could generate over $300,000,000 plus royalties to the company.
Take the time to listen to the conference call. It may entice you to buy a few shares for the Afrezza approval run.